相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Glial neuroimmune signaling in opioid reward
Hong Zhang et al.
BRAIN RESEARCH BULLETIN (2020)
The Endocannabinoid System Alleviates Pain in a Murine Model of Cancer-Induced Bone Pain
A. L. Thompson et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2020)
Cannabinoid CB1 receptor neutral antagonist AM4113 inhibits heroin self-administration without depressive side effects in rats
Xiang-hu He et al.
ACTA PHARMACOLOGICA SINICA (2019)
Deletion of Pregnancy Zone Protein and Murinoglobulin-1 Restricts the Pathogenesis of West Nile Virus Infection in Mice
Keeton Krause et al.
FRONTIERS IN MICROBIOLOGY (2019)
ABHD6: Its Place in Endocannabinoid Signaling and Beyond
Jessica K. Cao et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2019)
Endocannabinoid Regulation of Reward and Reinforcement through Interaction with Dopamine and Endogenous Opioid Signaling
J. M. Wenzel et al.
NEUROPSYCHOPHARMACOLOGY (2018)
The MEROPS database of proteolytic enzymes, their substrates and inhibitors in 2017 and a comparison with peptidases in the PANTHER database
Neil D. Rawlings et al.
NUCLEIC ACIDS RESEARCH (2018)
Effects of Cannabinoid Type 2 Receptor Agonist AM1241 on Morphine-Induced Antinociception, Acute and Chronic Tolerance, and Dependence in Mice
Mingyue Zhang et al.
JOURNAL OF PAIN (2018)
Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults - United States, 2016
James Dahlhamer et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats
Hai-Ying Zhang et al.
ADDICTION BIOLOGY (2017)
Synergistic attenuation of chronic pain using mu opioid and cannabinoid receptor 2 agonists
Shaness A. Grenald et al.
NEUROPHARMACOLOGY (2017)
The endocannabinoid hydrolysis inhibitor SA-57: Intrinsic antinociceptive effects, augmented morphine-induced antinociception, and attenuated heroin seeking behavior in mice
Jenny L. Wilkerson et al.
NEUROPHARMACOLOGY (2017)
Long-lasting antinociceptive effects of green light in acute and chronic pain in rats
Mohab M. Ibrahim et al.
PAIN (2017)
Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases
Marc P. Baggelaar et al.
ACS CHEMICAL BIOLOGY (2017)
Opioid and cannabinoid synergy in a mouse neuropathic pain model
Nicholas P. Kazantzis et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
The Perseus computational platform for comprehensive analysis of (prote)omics data
Stefka Tyanova et al.
NATURE METHODS (2016)
α/β-Hydrolase domain-containing 6 (ABHD6) negatively regulates the surface delivery and synaptic function of AMPA receptors
Mengping Wei et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Histidine-Rich Glycoprotein Prevents Septic Lethality through Regulation of Immunothrombosis and Inflammation
Hidenori Wake et al.
EBIOMEDICINE (2016)
The Prescription Opioid and Heroin Crisis: A Public Health Approach to an Epidemic of Addiction
Andrew Kolodny et al.
ANNUAL REVIEW OF PUBLIC HEALTH, VOL 36 (2015)
The Brain on Drugs: From Reward to Addiction
Nora D. Volkow et al.
CELL (2015)
NEURONAL EXPRESSION OF CB2 CANNABINOID RECEPTOR mRNAs IN THE MOUSE HIPPOCAMPUS
Y. Li et al.
NEUROSCIENCE (2015)
Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice
A. N. A. Verty et al.
PLOS ONE (2015)
Understanding opioid reward
Howard L. Fields et al.
TRENDS IN NEUROSCIENCES (2015)
Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol
Antonio Ortega-Alvaro et al.
ADDICTION BIOLOGY (2015)
GABAergic neurons in the ventral tegmental area receive dual GABA/enkephalin-mediated inhibitory inputs from the bed nucleus of the stria terminalis
Takehiro Kudo et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2014)
Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity
Yannick Marchalant et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2014)
Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina
Bruno Cecyre et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2014)
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice
Hai-Ying Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Endocannabinoid 2-arachidonoylglycerol self-administration by Sprague-Dawley rats and stimulation of in vivo dopamine transmission in the nucleus accumbens shell
Maria Antonietta De Luca et al.
FRONTIERS IN PSYCHIATRY (2014)
Evaluation of NHS Carbamates as a Potent and Selective Class of Endocannabinoid Hydrolase Inhibitors
Micah J. Niphakis et al.
ACS CHEMICAL NEUROSCIENCE (2013)
Mammalian Phospholipase C
Ganesh Kadamur et al.
ANNUAL REVIEW OF PHYSIOLOGY, VOL 75 (2013)
Involvement of CB1 receptors in the ventral tegmental area in the potentiation of morphine rewarding properties in acquisition but not expression in the conditioned place preference model
Ali Rashidy-Pour et al.
BEHAVIOURAL BRAIN RESEARCH (2013)
CCL5 and cytokine expression in the rat brain: Differential modulation by chronic morphine and morphine withdrawal
Lee A. Campbell et al.
BRAIN BEHAVIOR AND IMMUNITY (2013)
Role of CB2 Cannabinoid Receptors in the Rewarding, Reinforcing, and Physical Effects of Nicotine
Francisco Navarrete et al.
NEUROPSYCHOPHARMACOLOGY (2013)
Characterization of the Effects of Reuptake and Hydrolysis Inhibition on Interstitial Endocannabinoid Levels in the Brain: An in Vivo Microdialysis Study
Joost Wiskerke et al.
ACS CHEMICAL NEUROSCIENCE (2012)
Anti-Inflammatory Role of Fetuin-A in Injury and Infection
H. Wang et al.
CURRENT MOLECULAR MEDICINE (2012)
The effect of cannabinoid receptor 2 agonist JWH015 on the hyperalgesia induced by remifentanil
Z. Ma et al.
EUROPEAN JOURNAL OF ANAESTHESIOLOGY (2012)
Repeated morphine treatment-mediated hyperalgesia, allodynia and spinal glial activation are blocked by co-administration of a selective cannabinoid receptor type-2 agonist
Suneeta Tumati et al.
JOURNAL OF NEUROIMMUNOLOGY (2012)
Endocannabinoids Shape Accumbal Encoding of Cue-Motivated Behavior via CB1 Receptor Activation in the Ventral Tegmentum
Erik B. Oleson et al.
NEURON (2012)
Inhibitory Inputs from Rostromedial Tegmental Neurons Regulate Spontaneous Activity of Midbrain Dopamine Cells and Their Responses to Drugs of Abuse
Salvatore Lecca et al.
NEUROPSYCHOPHARMACOLOGY (2012)
Cannabinoid modulation of the dopaminergic circuitry: Implications for limbic and striatal output
Megan L. Fitzgerald et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Cannabinoid receptor signaling and modulation of monoamines: Implications for psychiatric and neurological disorders Preface
Elisabeth J. Van Bockstaele
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2012)
Serine proteases, serine protease inhibitors, and protease-activated receptors: Roles in synaptic function and behavior
Antoine G. Almonte et al.
BRAIN RESEARCH (2011)
Cannabinoid-Opioid Interaction in Chronic Pain
D. I. Abrams et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Brain cannabinoid CB2 receptors modulate cocaine's actions in mice
Zheng-Xiong Xi et al.
NATURE NEUROSCIENCE (2011)
Alternate Routes of Administration and Risk for HIV Among Prescription Opioid Abusers
Hilary Surratt et al.
JOURNAL OF ADDICTIVE DISEASES (2011)
Effects of fatty acid amide hydrolase inhibition on neuronal responses to nicotine, cocaine and morphine in the nucleus accumbens shell and ventral tegmental area: involvement of PPAR-α nuclear receptors
Antonio Luchicchi et al.
ADDICTION BIOLOGY (2010)
Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls
Matthew W. Buczynski et al.
BRITISH JOURNAL OF PHARMACOLOGY (2010)
Cannabinoid-opioid interactions during neuropathic pain and analgesia
Ittai Bushlin et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors
William R. Marrs et al.
NATURE NEUROSCIENCE (2010)
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources
Da Wei Huang et al.
NATURE PROTOCOLS (2009)
Statistical power analyses using G*Power 3.1: Tests for correlation and regression analyses
Franz Faul et al.
BEHAVIOR RESEARCH METHODS (2009)
Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area
Ferenc Matyas et al.
NEUROPHARMACOLOGY (2008)
A comprehensive profile of brain enzymes that hydrolyze the endocannabinoid 2-arachidonoylglycerol
Jacqueline L. Blankman et al.
CHEMISTRY & BIOLOGY (2007)
Interactions between CB1 cannabinoid and μ opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core
A. N. M. Schoffelmeer et al.
NEUROPHARMACOLOGY (2006)
Cannabinoid modulation of opiate reinforcement through the ventral striatopallidal pathway
S Caillé et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Cannabinoid agonists but not inhibitors of endogenous cannabinoid transport or metabolism enhance the reinforcing efficacy of heroin in rats
M Solinas et al.
NEUROPSYCHOPHARMACOLOGY (2005)
Synergistic and additive interactions of the cannabinoid agonist CP55,940 with μ opioid receptor and α2-adrenoceptor agonists in acute pain models in mice
SM Tham et al.
BRITISH JOURNAL OF PHARMACOLOGY (2005)
The opioid antagonist naltrexone reduces the reinforcing effects of Δ9-tetrahydrocannabinol (THC) in squirrel monkeys
Z Justinova et al.
PSYCHOPHARMACOLOGY (2004)
Synergistic interactions between cannabinoid and opioid analgesics
DL Cichewicz
LIFE SCIENCES (2004)
A cannabinoid receptor antagonist attenuates conditioned place preference but not behavioural sensitization to morphine
ME Singh et al.
BRAIN RESEARCH (2004)
Cannabinoid receptor antagonist reduces heroin self-administration only in dependent rats
M Navarro et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2004)
Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine
D Viganò et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2004)
SR141716A reduces the reinforcing properties of heroin but not heroin-induced increases in nucleus accumbens dopamine in rats
S Caillé et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
The cannabinoid CB1 antagonist N-piperidinyl-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methylpyrazole-3-carboxamide (SR-141716A) differentially alters the reinforcing effects of heroin under continuous reinforcement, fixed ratio, and progressive ratio schedules of drug self-administration in rats
M Solinas et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats
TJ De Vries et al.
PSYCHOPHARMACOLOGY (2003)
Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain
D Viganò et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Region-dependent changes in endocannabinoid transmission in the brain of morphine-dependent rats
S González et al.
ADDICTION BIOLOGY (2003)
Neuroadaptive effects of active versus passive drug administration in addiction research
EH Jacobs et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Cocaine, but not morphine, induces conditioned place preference and sensitization to locomotor responses in CB1 knockout mice
M Martin et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2000)
分享论文
